D-1300-2014 Class II Terminated
FDA drug recall D-1300-2014 was initiated by Wockhardt Usa Inc. on Apr 1, 2014 and is designated Class II. Reason for recall: Failed Dissolution Specifications: failure of dissolution test observed at nine month time point. The recall status is terminated (terminated May 12, 2015). Affected quantity: 109,744 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 14, 2014
- Initiation Date
- Apr 1, 2014
- Termination Date
- May 12, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 109,744 bottles
Product description
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, Rx only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ 07054, USA; NDC 64679-735-09, UPC 3 64679 73509 1.
Reason for recall
Failed Dissolution Specifications: failure of dissolution test observed at nine month time point.
Distribution pattern
Nationwide
Code information
Lot #: LN10686, LN10687, LN10688, LN10707, LN10708, Exp 02/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1300-2014
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026